首页> 外国专利> METHOD FOR TREATMENT OF HYPERHOMOCYSTENEMIA IN PATIENTS WITH CHRONIC RENAL INSUFFICIENCY AND TREATED BY HEME-DIALYSIS OR HEME-FILTRATION

METHOD FOR TREATMENT OF HYPERHOMOCYSTENEMIA IN PATIENTS WITH CHRONIC RENAL INSUFFICIENCY AND TREATED BY HEME-DIALYSIS OR HEME-FILTRATION

机译:血液透析或血液滤过治疗慢性肾功能不全患者的高血脂症的方法

摘要

FIELD: medicine.;SUBSTANCE: before onset of treatment or in the process of treatment patient is administrated 2,3-dimercaptopropane sodium sulfonate in the dose 50-500 mg by subcutaneous or intramuscular route depending on the patient mass and the expression degree of hyperhomocysteinemia. Method provides normalization of blood level homocysteine due to its elimination from body as reduced homocysteine after its complete release from blood protein-bound form and with retention of these proteins in circulation. Invention can be used in treatment of patients with renal insufficiency with the enhanced blood content of homocysteine who have increased concentration of low- and mean-molecular metabolites due to disturbance in urine formation and when carrying out heme-dialysis or heme-filtration is required.;EFFECT: improved treatment method.;5 ex
机译:领域:药物;物质:在治疗开始前或治疗过程中,根据患者质量和高同型半胱氨酸血症的表达程度,通过皮下或肌内途径向患者施用50-500 mg剂量的2,3-二巯基丙烷磺酸钠。该方法提供了血液水平高半胱氨酸的归一化,这是由于从血液中结合的高半胱氨酸从血液中完全释放出来之后,其水平降低,而高半胱氨酸从蛋白质结合形式中完全释放出来,并且这些蛋白质在循环中得以保留。本发明可用于治疗具有高半胱氨酸的血液含量增加的肾功能不全的患者,这些患者由于尿液形成的干扰而需要进行血红素透析或血红素过滤时,其低分子和中分子代谢物的浓度增加。 ;效果:改良的治疗方法。; 5前

著录项

  • 公开/公告号RU2261702C1

    专利类型

  • 公开/公告日2005-10-10

    原文格式PDF

  • 申请/专利权人

    申请/专利号RU20040128400

  • 申请日2004-09-23

  • 分类号A61K31/10;A61P3/00;A61M1/34;

  • 国家 RU

  • 入库时间 2022-08-21 22:01:58

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号